Clinical Trial Update: Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Vardenafil ODT to placebo in men with erectile dysfunction; results were posted after the study completed (no efficacy details provided …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Vardenafil ODT (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2011-01-21